Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Stimcell Energetics, Inc. (STME)
USD0.28
+0.00 (+0.00%)
CA OTC Healthcare Medical - Devices
Address
1130 Pender Street, West V6E 4A4
Vancouver, BC, CA
Vancouver, BC, CA
CEO
David Jeffs
Website
stimcell.com
IPO
2013-08-29
CIK 1493712 ISIN US15115X2062
Also trades on
Other OTC · CMXC (USD)
Other OTC · STME (USD)
Description
StimCell Energetics Inc. is a biotechnology company focused on the research, development, and market introduction of both therapeutic and non-therapeutic solutions. These products are intended to benefit individuals in the United States who are managing conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and issues with kidney function. The company's primary product line is the eBalance system, which comprises two versions: the eBalance Pro System, designed for clinical application by healthcare practitioners, and the eBalance Home System, created for personal use to promote overall well-being and alleviate pain. Both systems are operated via the eBalance Console, a central control unit that offers three distinct pre-programmed microcurrent algorithms: one for general wellness, another for pain relief, and a 'dual' mode that combines both. Additionally, these eBalance products aim to provide temporary relief for discomfort in various body parts, including the shoulders, waist, back, neck, arms, and legs. Established in 2010, the company initially operated under the name Cell MedX Corp. before officially rebranding as StimCell Energetics Inc. in November 2024. Its corporate headquarters are located in Vancouver, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.28
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
957
Beta
48.49
Float Shares
5.84M
Free Float %
27.9%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.28
DCF (Levered)
0.00
-99.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
-522.04
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%-782.4% Q1'26: +39.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-52.0% ★ Q1'26: +5.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×—
Valuation Multiples
From
To
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-284.4K
OE per share TTM
-0.01
Owner's Yield
-3.89%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
2.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
16.7K
Shares disposed
—
Cash buys
—
Cash sales
1.00
Net activity
+16,667
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | Vahabzadeh Amir | Director / 10% Owner | S-Sale | A | Common Shares | 16,667 | 0.34 | 5.7K | 4,164,566 | D | ↗ |
| 2025-03-17 | Vahabzadeh Amir | Director / 10% Owner | A-Award | D | Common Shares | 198,000 | 0.22 | 43.6K | 4,133,676 | D | ↗ |
| 2025-02-24 | JEFFS RICHARD | 10% Owner | P-Purchase | D | Common Shares | 4,399 | 0.20 | 879.80 | 1,688,889 | D | ↗ |
| 2025-02-21 | JEFFS RICHARD | 10% Owner | P-Purchase | D | Common Shares | 15,000 | 0.16 | 2.4K | 1,693,288 | D | ↗ |
| 2024-11-01 | Vahabzadeh Amir | Director / 10% Owner | F-InKind | D | Common Shares | 60,643,472 | 0.00 | — | 4,331,676 | D | ↗ |
| 2024-11-01 | JEFFS RICHARD | 10% Owner | F-InKind | D | Common Shares | 239,160,254 | 0.00 | — | 1,708,288 | D | ↗ |
| 2023-12-29 | daCosta Joao | Director | A-Award | A | Common Shares | 531,687 | 0.01 | 3.7K | 2,061,687 | — | ↗ |
| 2023-12-29 | Yaretz Dwayne | Director | A-Award | A | Common Shares | 1,214,285 | 0.01 | 8.5K | 1,214,285 | — | ↗ |
| 2023-12-29 | Vahabzadeh Amir | Director / 10% Owner | A-Award | A | Common Shares | 61,755,148 | 0.01 | 432.3K | 64,975,148 | — | ↗ |
| 2023-12-29 | Jeffs David | Director / Officer / 10% Owner | A-Award | A | Common Shares | 73,959,726 | 0.01 | 517.7K | 73,959,726 | — | ↗ |
| 2023-12-29 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 14,372,285 | 0.01 | 100.6K | 25,624,313 | — | ↗ |
| 2023-12-12 | Vahabzadeh Amir | Director | — | D | Common Shares | 0 | 0.00 | — | 3,220,000 | — | ↗ |
| 2023-12-12 | Jeffs David | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-25 | Yaretz Dwayne | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-02-07 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 300 | 0.18 | 54.00 | 5,481,647 | — | ↗ |
| 2022-02-04 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 7,000 | 0.15 | 1.1K | 5,482,247 | — | ↗ |
| 2022-01-05 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 7,500 | 0.15 | 1.1K | 5,489,247 | — | ↗ |
| 2021-12-29 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.18 | 922.50 | 5,496,747 | — | ↗ |
| 2021-12-20 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 18.20 | 91.0K | 5,501,747 | — | ↗ |
| 2021-12-15 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 4,654 | 0.19 | 884.26 | 5,506,747 | — | ↗ |
| 2021-11-24 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 20,000 | 0.17 | 3.4K | 5,511,401 | — | ↗ |
| 2021-09-14 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.20 | 2.0K | 5,551,401 | — | ↗ |
| 2021-09-09 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.22 | 2.2K | 5,561,401 | — | ↗ |
| 2021-08-02 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 6,500 | 0.26 | 1.7K | 5,571,401 | — | ↗ |
| 2021-07-29 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.26 | 2.6K | 5,577,901 | — | ↗ |
| 2021-07-27 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.26 | 2.6K | 5,587,901 | — | ↗ |
| 2021-07-23 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 351 | 0.28 | 98.28 | 5,597,901 | — | ↗ |
| 2021-07-22 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.25 | 2.5K | 5,598,252 | — | ↗ |
| 2021-07-01 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 9,000 | 0.26 | 2.3K | 5,608,252 | — | ↗ |
| 2021-06-25 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 8,000 | 0.25 | 2.0K | 5,617,252 | — | ↗ |
| 2021-06-23 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 8,000 | 0.25 | 2.0K | 5,625,252 | — | ↗ |
| 2021-06-16 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.29 | 1.5K | 5,633,252 | — | ↗ |
| 2021-06-15 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.28 | 1.4K | 5,638,252 | — | ↗ |
| 2021-06-14 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.24 | 1.2K | 5,643,252 | — | ↗ |
| 2021-05-27 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 5,000 | 0.28 | 1.4K | 5,648,252 | — | ↗ |
| 2021-04-27 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.27 | 2.7K | 5,685,402 | — | ↗ |
| 2021-04-22 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 10,000 | 0.26 | 2.6K | 5,695,402 | — | ↗ |
| 2021-04-21 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 25,000 | 0.26 | 6.5K | 5,705,402 | — | ↗ |
| 2021-04-20 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 24,780 | 0.27 | 6.6K | 5,730,402 | — | ↗ |
| 2021-04-19 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 22,562 | 0.25 | 5.6K | 5,805,182 | — | ↗ |
| 2021-04-16 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 23,500 | 0.22 | 5.2K | 5,827,744 | — | ↗ |
| 2021-04-06 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 20,000 | 0.23 | 4.6K | 5,851,244 | — | ↗ |
| 2021-03-26 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 18,911 | 0.27 | 5.1K | 5,871,244 | — | ↗ |
| 2021-03-21 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | S-Sale | D | Common stock | 25,000 | 0.22 | 5.5K | 5,909,855 | — | ↗ |
| 2020-12-03 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | G-Gift | D | Common Shares | 300,000 | 0.00 | — | 5,934,855 | — | ↗ |
| 2020-08-13 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | M-Exempt | A | Common Shares | 1,234,855 | 0.05 | 61.7K | 6,234,855 | — | ↗ |
| 2020-08-13 | ARNETT JEAN M | 10% Owner | M-Exempt | A | Common Shares | 1,250,000 | 0.05 | 62.5K | 6,250,000 | — | ↗ |
| 2020-07-30 | MCENULTY FRANK | Director / Officer | P-Purchase | A | Common Shares | 40,000 | 0.25 | 10.0K | 521,016 | — | ↗ |
| 2020-06-08 | daCosta Joao | Director / Officer | — | D | COMMON SHARES | 0 | 0.00 | — | 1,530,000 | — | ↗ |
| 2020-04-28 | JEFFS RICHARD | 10% Owner | S-Sale | D | Common Shares | 1,665 | 0.60 | 999.00 | 11,252,028 | — | ↗ |
| 2020-04-27 | JEFFS RICHARD | 10% Owner | S-Sale | D | Common Shares | 15,607 | 0.60 | 9.4K | 11,253,693 | — | ↗ |
| 2020-04-24 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 5,500 | 0.42 | 2.3K | 11,269,300 | — | ↗ |
| 2020-04-21 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 1,000,000 | 0.15 | 150.0K | 11,263,800 | — | ↗ |
| 2020-04-16 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 5,000 | 0.32 | 1.6K | 10,263,800 | — | ↗ |
| 2020-04-15 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 5,000 | 0.33 | 1.6K | 10,258,800 | — | ↗ |
| 2020-04-14 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 10,000 | 0.29 | 2.9K | 10,238,800 | — | ↗ |
| 2020-04-13 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 17,100 | 0.30 | 5.1K | 10,228,800 | — | ↗ |
| 2020-04-09 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 25,000 | 0.30 | 7.5K | 10,206,400 | — | ↗ |
| 2020-04-08 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 8,000 | 0.29 | 2.3K | 10,181,400 | — | ↗ |
| 2020-04-03 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 30,000 | 0.21 | 6.3K | 10,173,400 | — | ↗ |
| 2020-02-06 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 10,000 | 0.30 | 3.0K | 10,143,400 | — | ↗ |
| 2020-01-30 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 10,000 | 0.25 | 2.5K | 10,133,400 | — | ↗ |
| 2019-12-12 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 25,000 | 0.24 | 6.0K | 10,123,400 | — | ↗ |
| 2019-09-09 | JEFFS RICHARD | 10% Owner | X-InTheMoney | D | Warrants | 3,000,000 | 0.05 | 150.0K | 2,000,000 | — | ↗ |
| 2019-08-13 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 6,064 | 0.31 | 1.8K | 2,612,940 | — | ↗ |
| 2019-08-07 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 16,000 | 0.15 | 2.4K | 2,606,876 | — | ↗ |
| 2019-07-29 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 14,700 | 0.15 | 2.1K | 2,590,876 | — | ↗ |
| 2019-07-24 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 200 | 0.16 | 32.00 | 2,576,176 | — | ↗ |
| 2019-07-18 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 8,500 | 0.18 | 1.5K | 2,575,976 | — | ↗ |
| 2019-06-27 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 1,100 | 0.17 | 187.00 | 2,567,476 | — | ↗ |
| 2019-02-08 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 50,000 | 0.14 | 7.0K | 2,566,376 | — | ↗ |
| 2019-02-04 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 250 | 0.12 | 30.00 | 2,516,376 | — | ↗ |
| 2018-12-27 | JEFFS RICHARD | 10% Owner | A-Award | A | Warrant | 5,000,000 | 0.05 | 250.0K | 5,000,000 | — | ↗ |
| 2018-03-23 | Adams George | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-12-01 | Owen Terrance George | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-10-12 | MCENULTY FRANK | Director / Officer | P-Purchase | A | Common Shares | 481,016 | 0.25 | 120.3K | 481,016 | — | ↗ |
| 2017-08-24 | daCosta Joao | Director / Officer | — | I | Stock Options (Right to Buy) | 1,500,000 | 0.35 | 525.0K | 0 | — | ↗ |
| 2017-08-24 | SILINA YANIKA S | Director / Officer | A-Award | A | Options | 300,000 | 0.35 | 105.0K | 300,000 | — | ↗ |
| 2017-08-21 | JEFFS RICHARD | 10% Owner | P-Purchase | A | Common Shares | 1,000 | 0.29 | 290.00 | 2,516,126 | — | ↗ |
| 2016-09-26 | HARGREAVES BRADLEY S | Director / Officer / 10% Owner | J-Other | D | Stock Options (Right to Buy) | 2,500,000 | 0.05 | 125.0K | 0 | — | ↗ |
| 2016-09-26 | ARNETT JEAN M | 10% Owner | J-Other | D | Stock Options (Right to Buy) | 2,500,000 | 0.05 | 125.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
20.89M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David Jeffs | President, Chief Executive Officer & Director | 80.4K | male |
| Yanika Silina | Chief Financial Officer, Treasurer, Corporate Secretary & Director | 30.0K | female |
ESG Rating
ESG Score History
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STME
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
